Fog Pharmaceuticals Company
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015
Estimated Revenue:
$1M to $10M
Register and Claim Ownership